Document Detail


Inhaled gentamicin in non-cystic fibrosis bronchiectasis: effects of long-term therapy.
MedLine Citation:
PMID:  21470074     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Bronchiectasis is a disease state defined by irreducible dilations of the airways. If they occur in diseases other than cystic fibrosis they are termed non-CF bronchiectasis. The common denominator is the increased risk of recurrent infections with bacteria, such as Staphylococcus aureus or Pseudomonas aeruginosa. Such infections are difficult to eradicate with systemic antibiotics because the structural abnormalities in the bronchial wall reduce their bactericidal effect at this level. An alternative to systemic antibiotics might be represented by inhaled formulations, which can be given in much lower doses and can be more effective. Previous studies demonstrated that inhaled gentamicin can reduce bacterial load and local infection in both cystic fibrosis and non-CF bronchiectasis. The study discussed in this paper demonstrates that long-term therapy with inhaled gentamicin can eradicate the infection or reduce the bacterial load, decrease the risk of subsequent infections and improve the quality of life in patients with non-CF bronchiectasis with a minimal risk of side effects.
Authors:
Sabina A Antoniu; Antigona Carmen Trofor
Related Documents :
18062904 - The thymus as a target for mycobacterial infections.
6709554 - Breast mycobacterial infection in a haemodialysis patient.
2182904 - Pulmonary disease caused by nontuberculous mycobacteria.
19834604 - Correction: mycobacterium tuberculosis universal stress protein rv2623 regulates bacill...
8125714 - Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
23588134 - Natural history of mycoplasma genitalium infection in a cohort of female sex workers in...
Publication Detail:
Type:  Journal Article     Date:  2011-04-07
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  12     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1191-4     Citation Subset:  IM    
Affiliation:
University of Medicine and Pharmacy "Gr.T.Popa" Iasi, Pulmonary Disease University Hospital, Department of Medicine II - Pulmonary Disease, 30 Dr I Cihac Str, 700115 Iasi, Romania +0040232239408 ; Sabina.antonela.antoniu@pneum.umfiasi.ro.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transarterial therapies for hepatocellular carcinoma.
Next Document:  Calorie restriction modulates hippocampal NMDA receptors in diet-induced obese rats.